Auda A. Eltahla is a hepatologist based in Sydney, NSW, Australia.
Her work focuses on the liver and on health issues that can come along with liver disease. In many cases, people see her because they want answers and a clear plan for what to do next, not just quick fixes.
A big part of her practice is hepatitis care, including hepatitis C. Hepatitis C can affect the liver for years, sometimes quietly, so getting the right checks and treatment steps matters. She helps patients understand the results, what the risks are, and what options are available. At times, that can also mean supporting people through follow-up tests to see how things are going over time.
She also looks after people dealing with Hairy Cell Leukemia (HCL). This is a rare blood cancer, and it can be hard to manage on its own. People may feel worn out or worried, and the path forward can be confusing. She works to coordinate care with the wider team, focusing on the liver side of the picture while keeping the person’s overall health in mind.
Because these conditions can affect the body in different ways, her approach is practical. She tends to explain things in simple terms and keeps the focus on next steps. That means talking through what symptoms to watch, why certain tests are ordered, and how treatment decisions are made based on the situation.
In terms of experience, her clinic work is centred around hepatitis and hepatitis C, plus managing patients with HCL where liver health is part of the bigger story. She is used to working with people who feel anxious about long-term illness, and she makes room for questions along the way.
On the education side, the key details available here aren’t listed, so that part isn’t included. There’s also no specific research or clinical trials information provided in this listing.
Overall, Auda Eltahla is a Sydney hepatologist who helps patients who are dealing with liver-related illness, especially hepatitis and hepatitis C, and who also supports people managing Hairy Cell Leukemia when it overlaps with liver concerns.